Coeliac disease (CD) is an autoimmune enteropathy triggered by gluten and characterized by a strong T helper type 1 (Th1)/Th17 immune response in the small intestine. Regulatory T cells (T reg ) are CD4 1 CD25 11 forkhead box protein 3 ( FoxP3 1 ) cells that regulate the immune response. Conversely to its counterpart, FoxP3 full length (FL), the alternatively spliced isoform FoxP3 D2, cannot properly down-regulate the Th17-driven immune response. As the active state of CD has been associated with impairments in T reg cell function, we aimed at determining whether imbalances between FoxP3 isoforms may be associated with the disease. Intestinal biopsies from patients with active CD showed increased expression of FOXP3 D2 isoform over FL, while both isoforms were expressed similarly in non-coeliac control subjects (HC). Conversely to what we saw in the intestine, peripheral blood mononuclear cells (PBMC) from HC subjects did not show the same balance between isoforms. We therefore hypothesized that the intestinal microenvironment may play a role in modulating alternative splicing. The proinflammatory intestinal microenvironment of active patients has been reported to be enriched in butyrate-producing bacteria, while high concentrations of lactate have been shown to characterize the preclinical stage of the disease. We show that the combination of interferon (IFN)-g and butyrate triggers the balance between FoxP3 isoforms in HC subjects, while the same does not occur in CD patients. Furthermore, we report that lactate increases both isoforms in CD patients. Collectively, these findings highlight the importance of the ratio between FoxP3 isoforms in CD and, for the first time, associate the alternative splicing process mechanistically with microbial-derived metabolites.
Introduction

Regulatory T cells (T reg ) represent a subset of CD4
1 T cells that control the immune response to foreign antigens and maintain self-tolerance [1, 2] . T reg cells can mediate suppression of responder cells through different mechanisms, including the production of immunosuppressive cytokines, the consumption of IL-2 and the down-regulation of costimulatory molecules on antigen-presenting cells (APC) [3] . The nuclear transcription factor forkhead box protein 3 (FoxP3) has been described to be fundamental in regulating the differentiation and function of T reg cells [4, 5] . Indeed, mutations located on the FOXP3 gene have been associated with the onset of several autoimmune diseases, such as immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), type 1 diabetes, Grave's disease and systemic lupus erythematosus (SLE) [6] [7] [8] [9] [10] . Like other members of the Fox protein family, FoxP3 is characterized by a highly conserved forkhead DNA-binding domain, a leucine zipper-like domain and a zinc finger motif. Finally, a unique proline-rich repressor domain is located on the Nterminal region [11] . This domain plays a fundamental role in modulating the regulatory functions of FoxP3 by interacting with other transcription factors [11] [12] [13] . Furthermore, it has been shown to be important for maintaining the anergic state of T reg cells [14] and regulating the balance between T reg and T helper type 17 (Th17) cells [15] [16] [17] .
Several FoxP3 alternatively spliced isoforms have been described. They are present only in human cells, and no animal counterparts have been reported [18] . The most common isoforms are the full-length (FL) and Delta 2 (D2), which lacks exon 2 [17] [18] [19] . Although both these isoforms have been shown to confer some suppressive ability to T reg cells [18] , they seem to have functional differences. Exon 2 is located on the N-terminal repressor domain and contains the binding site for retinoic acid-related orphan receptors (RORgT and RORaT). By interacting with RORaT and RORgT, FoxP3 FL down-regulates their expression and inhibits Th17 differentiation, while FoxP3 D2 does not [17] .
Coeliac disease (CD) is an autoimmune enteropathy triggered by ingestion of gluten in genetically predisposed individuals [20, 21] . Th1 cells are known to be important players in the cascade of events that leads to intestinal inflammation in CD patients by producing proinflammatory cytokines interferon (IFN)-g and tumor necrosis factor (TNF)-a [22, 23] . IFN-g is also produced in large amounts by CD8
1 intraepithelial lymphocytes (IELs). These cells are expanded in the small intestine of active coeliac patients and contribute to the pathogenesis of the disease not only by secreting proinflammatory cytokines, but also through cytolytic proteins such as perforin and granzymes [20, 24] . Recently, Th17-associated cytokines have also been reported to be increased in the small intestinal mucosa of active CD patients [25] [26] [27] , therefore suggesting a role of Th17 cells in the pathogenesis of CD. While deficiencies in the population of T reg cells have been associated with other autoimmune diseases such as systemic lupus erythematosus (SLE) [28] , CD is characterized by an increased number of FoxP3 1 cells in the lamina propria of the small intestine [29, 30] . Several groups have shown that their suppressive function is impaired significantly [31] [32] [33] , but the exact mechanisms behind these deficiencies are not understood fully. In the present study, we show that in CD patients the D2 isoform is overexpressed compared to FL in FoxP3-positive cells homing in the gut mucosa and that the intestinal microenvironment, characterized by high production of proinflammatory cytokines and specific microbial-derived metabolites, may contribute to this disequilibrium. This evidence is the first instance of linking changes in the intestinal microenvironment to host epigenetic modifications associated mechanistically with immune surveillance.
Methods
Human subjects
Whole blood was obtained by venipuncture from adult patients aged between 16 and 65 years and distributed similarly between both sexes during routine visits to our clinic at Massachusetts General Hospital. Patients included noncoeliac control subjects (HC), coeliac patients in remission following a gluten-free diet (CDGF) with normal duodenal pathology (Marsh 0-II) and coeliac patients with active disease (CDA). Small intestinal biopsies were obtained from the second portion of the duodenum according to standard clinical procedure from HC, CDGF and CDA during clinically indicated upper endoscopic procedures. Patients with CD in the cohort were diagnosed based on pathological evaluation (Marsh III at time of diagnosis) and positive serology results for anti-human tissue transglutaminase immunoglobulin (Ig)A antibodies (Inova Diagnostics Inc., San Diego, CA, USA) (the manufacturer's instructions were followed and samples were evaluated as positive if values of TtG-IgA !20 were detected). Patients were considered CDGF if, at the time of specimen collection, they have been following a gluten-free diet for at least 6 months and presented negative serology and normal intestinal mucosa (Marsh 0-II).
Peripheral blood mononuclear cell (PBMC) isolation and stimulation PBMC were isolated from whole blood samples by density gradient centrifugation over Ficoll (GE Healthcare, Rahway, NJ, USA) and cultured (1 3 10 6 cells/ml) for 24 or 48 h in complete medium RPMI-1640 Dutch modification (GIBCO, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich, St Louis, MO, USA), 1% L-glutamine, 1% penicilin/streptomycin, 1% sodium pyruvate and 1% non-essential amino acid solution (GIBCO) with 1 mg/ml of previously digested gliadin (Sigma) [34] , 100 ng/ml of IFN-g (eBioscience, San Diego, CA, USA), 1 lg/ml lactate (Sigma) or butyrate (Sigma) and a combination of IFN-g and butyrate at 378C, 5% CO 2 .
Isolation and stimulation of CD4
1 CD25 -and CD4
1
CD25
1 T cells form peripheral blood and flow cytometry 
-and CD4 1 CD25 1 T cells were isolated from PBMC with the dynabeads CD4 1 CD25 1 T reg cells isolation kit (Invitrogen, Carlsbad, CA, USA). CD4 1 CD25 -T cells were isolated by negative selection and stimulated with 1 lg/ml of lactate or with a combination of 1 lg/ml of butyrate and 100 ng/ml of IFN-g for 48 h in complete RPMI-1640 medium enriched with 10% FBS, 50 U/ml of recombinant IL-2 (rIL2) (eBioscience) and CD3/CD28 dynabeads (Invitrogen). T reg cells were isolated by positive selection, expanded in complete RPMI-1640 medium enriched with 10% FBS, 500 U/ml of rIL-2, CD3/CD28 dynabeads and cultured with the different stimuli for 48 h. Purity of the different T cell populations was higher than 90% and determined by flow cytometry. Briefly, isolated T cells were stained with antibodies peridinin chlorophyll (PerCP)-conjugated anti-CD4 (eBioscience) and phycoerythrin (PE)-conjugated anti-CD25 (eBioscience). Cells were 
Western blot
Protein lysates from PBMC before and after stimulation with butyrate and IFN-g were obtained by lysing the cells in radioimmunoprecipitation assay (RIPA) buffer (Sigma) and protease inhibitors cocktail (Roche). Cells were agitated for 15 min at 48C and centrifuged at 1789 g for 15 min at 48C. Protein concentrations were measured with the detergent compatible (DC) protein assay (Biorad, Hercules, CA, USA). Samples were denaturated at 958C for 5 min and separated on 4-20% Novex Tris-Glycine gels (Life Technologies, Paisley, UK) at 100 V for 2 h. Proteins were then transferred to polyvinylidene fluoride (PVDF) membranes (Life Technologies) using the X Cell Blot Module (Invitrogen) at 25 V for 2 h at 48C. Membranes were blocked with 5% bovine serum albumin (BSA) and incubated with isoform non-specific a-FoxP3 (PHC101; eBioscience) at a concentration of 4 lg/ml, followed by washing and incubation with secondary horseradish peroxidase (HRP)-conjugated antibody (GE Healthcare). Protein bands were visualized by the enhanced chemiluminescence (ECL) Western blotting substrate kit (Abcam, Cambridge, UK). B-actin protein (a2b actin; Thermo-Fisher) was used to normalize the relative protein expression.
Statistics
Depending on the sample distribution, statistical analysis of the samples was performed by t-test, two-tailed Mann-Whitney test (unpaired samples) and paired t-test or Wilcoxon's test (paired samples) as appropriate. Standard error of the mean (s.e.m.) was measured to determine the dispersion among data within the same group. In all statistical tests, a P-value less than 0Á05 was considered significant. Correlation between gene expressions was measured by two-tailed Spearman's or Pearson's correlation analysis, depending on the sample distribution.
Study approval
All protocols were approved by the Partners Human Research Committee Institutional Review Board and written informed consent was obtained from all enrolled subjects.
Results
Altered expression of FoxP3 isoforms in the intestine of active coeliac patients
We measured the expression of total FOXP3 in the small intestine of CDA patients and HC subjects and also the expression of each FOXP3 isoform in HC, CDA and CDGF patients by performing a real-time reverse transcriptionpolymerase chain reaction (RT-PCR). As reported in previous studies, CDA patients showed an increased expression of total FOXP3 compared to HC subjects (P < 0Á005) (Fig. 1a) . The comparison between CDA and HC showed no differences in the expression of FOXP3 FL, while the D2 isoform appeared expressed more significantly in a subgroup of CDA patients compared to the HC (P < 0Á05). Interestingly, the analysis in CDGF patients showed that this group of subjects expressed higher levels of both FOXP3 isoforms compared to either HC either CDA subjects (Fig. 1b) . The analysis between FOXP3 isoforms ratios (D2/FL) showed no differences between HC subjects and CDGF patients, while in CDA patients the ratio between the two isoforms was significantly higher than in the other groups of subjects (P < 0Á05) (Fig. 1c) . Relative expression of forkhead box protein 3 (FOXP3) isoforms, retinoic acid-related orphan receptors (RORcT) and interleukin (IL) 17A in small intestinal biopsies. Real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to measure the relative expression of total FOXP3 in healthy subjects (HC n 5 18) and active coeliac patients (CDA n 5 20) (a). Specific primers were used to measure the relative expression of both FOXP3 isoforms separately in HC, CDA and coeliac patients in remission following a gluten-free diet (CDGF) (n 5 8) (b). The ratio between the relative expression of FOXP3 D2 and FL (D2/FL) was calculated individually for each subject and compared among the three groups of patients. The bars show the mean of the ratios 6 standard error of the mean (s.e.m.) in small intestinal biopsies of HC (white bars), CDA (black bars) and CDGF patients (grey bars) (c). Paired analysis was used to determine further the differences between the two isoforms' expression within the same group of patients (d). Each dot represents the mean among the mRNA expression values 6 s.e.m. Relative expression of RORcT was measured in small intestinal biopsies form HC (n 5 13), CDA (n 5 13) and CDGF (n 5 9) (e). Positive correlation between the expression of RORcT and FOXP3 D2 was determined on the CDA samples for which we had both gene values (n 5 13) by two-tailed Spearman's correlation analysis (f). Relative expression of IL17A was measured in small intestinal biopsies of HC (n 5 6) and CDA (n 5 8) (G). Positive correlation between the expression of IL17A and FOXP3D2 was determined on CDA samples (n 5 8) by two-tailed Pearson correlation analysis (h). Real-time RT-PCR data were normalized to housekeeping gene 18S. Statistical comparisons were made using the Mann-Whitney Utest (a,b,g), unpaired t-test (c,e) and Wilcoxon's or paired t-test (d). *P < 0Á05; **P < 0Á005. Furthermore, a paired analysis between isoforms revealed that in CDA patients FOXP3 D2 was expressed significantly more than its counterpart FL, while in HC and CDGF subjects the two isoforms were expressed similarly (Fig. 1d) . The alternatively spliced isoform FoxP3 D2 has been described to be less efficient in down-regulating RORgT expression [17] . To evaluate if the elevated intestinal expression of FOXP3 D2 that we found in CDA patients matched with a higher expression of RORcT, we performed real time RT-PCR on the mRNA extracted from whole biopsies of HC subjects, CDA and CDGF patients. Although the different expression of RORcT among the groups did not reach statistical significance, it appeared to be higher in a subgroup of CDA patients (Fig. 1e) . Furthermore, our data showed a positive correlation between the expression of RORcT and FOXP3 D2 in CDA patients (Fig. 1f) . Analysis of IL17A mRNA between another set of CDA patients and HC subjects confirmed that the increased RORcT expression that we found in biopsies of CDA patients matched with higher Th17 proinflammatory cytokine IL17A (Fig. 1g) . Additionally, we found that in CDA subjects the expression of IL17A was correlated positively with the expression of FOXP3D2 (Fig. 1h) . To confirm that the differences in FOXP3 isoforms expression that we saw in the whole small intestinal biopsies were due to changes in the T reg population, we isolated CD4 1 cells from the small intestinal biopsies of HC and CDA patients and measured the genic expression of both isoforms by real-time RT-PCR. Our data not only showed a significantly higher expression of FOXP3 D2 in CDA compared to HC subjects (P < 0Á05) (Fig. 2a) , but also confirmed that in CDA patients the less functional isoform is more expressed than its counterpart FL, while in HC subjects the two isoforms are expressed at similar levels (P < 0Á05) (Fig. 2b,c) . Finally analysis of RORcT expression in the same samples confirmed a higher expression of the Th17 transcription factor in CDA patients (Fig. 2d) that correlated with the expression of the alternatively spliced isoform FOXP3 D2 (Fig. 2e) .
Regulation of FoxP3 isoforms in coeliac disease
Peripheral blood expression of FoxP3 isoforms is similar between coeliac patients and control subjects
The intestinal microenvironment is unique and highly diverse. To evaluate if the differences found in biopsies of CDA patients represented an event restricted exclusively to the intestinal compartment, we measured the expression of FOXP3 isoforms and RORcT by real-time RT-PCR on mRNA extracted from PBMC of HC subjects, CDA and CDGF patients. Our data did not show a significant difference among the three groups of patients (Fig. 3a) . Interestingly, the ratios (D2/FL) between isoforms were similar in all groups (Fig. 3b ) and the alternatively spliced isoform FOXP3 D2 appeared more expressed than the FL (P < 0Á05) (Fig. 3c) . Furthermore, data on RORcT expression did not reveal differences in the expression of the transcription factor between CDA and HC (Fig. 3d) .
Pepsin-trypsin (PT)-gliadin does not affect the ratio between FoxP3 isoforms expression
Gliadin is the recognized environmental trigger for CD and, to this day, the complete elimination of gluten from the diet is the only efficient treatment for CD patients. Given that gliadin peptides have been shown to interact with immune cells in the lamina propria of the small intestine during the active state of the disease, we hypothesized that they may trigger the sustained imbalance between FOXP3 isoforms in genetically predisposed individuals. This would then explain the lack of the same phenomenon when the subjects are in remission following gluten elimination from the diet. To test our hypothesis, we stimulated PBMC from HC and CD patients in remission with pepsin-trypsin gliadin digest (PTG). PTG did not trigger a higher expression of FOXP3 D2 in CD patients compared to HC subjects (Fig. 4a) . Our paired analysis showed that in both groups of patients, even after stimulation with PTG, FOXP3 D2 was more expressed than FL (P < 0Á05) (Fig. 4b) . Furthermore, we did not see changes in FOXP3 isoforms ratio (D2/FL) after stimulation (Fig. 4c ). Relative expression of IL6 was measured in PBMC from both groups to ensure the efficacy of the stimulation with PTG (Fig. 4d ).
Combined effect of proinflammatory cytokine IFN-g plus butyrate on modulating the ratio between FoxP3 isoforms expression in PBMC.
We reasoned that the imbalance between FoxP3 isoforms observed in CDA subjects may be due to the unique intestinal microenvironment of these patients. A major feature of the cascade of events that lead to enteric damage in CD is the adaptive Th1-driven immune response and its consequent high production of the proinflammatory cytokine IFN-g [22] . The active state of the disease has also been associated with high levels of the microbial-derived metabolite butyrate [35, 36] . To determine the role of the intestinal microenvironment in modulating FoxP3 isoform expression, we stimulated PBMC from HC and CD patients with a combination of IFN-g plus butyrate. In either group of patients the relative expression of each FoxP3 isoform did not change upon stimulation (Fig. 5a ).
The comparison between individual ratios (D2/FL) showed a significant skew towards FoxP3 D2 in CD subjects compared to the control group (P < 0Á05) (Fig. 5b) . Interestingly, our paired analysis between isoforms revealed that in HC subjects the combination of butyrate and IFN-g appeared to trigger a balance between the two FoxP3 isoforms, which showed similar expression levels (Fig. 5c) . Conversely, PBMC from CD patients maintained the imbalanced ratio between isoforms (P < 0Á005) after stimulation when compared to non-stimulated cells. The acquired balance between FoxP3 isoforms in HC subjects mimicked what we saw in the intestinal samples. Furthermore, it matched with a significant decrease of RORgT mRNA expression after stimulation (P < 0Á05), while no differences in RORgT expression occurred in CD patients (Fig. 5d) . Interestingly, we showed a negative correlation between the expression of RORgT and FL/D2 ratio in HC subjects (Fig. 5e) . Western blot analysis confirmed the presence of the two isoforms at the protein level before and after stimulation with butyrate and IFN-g in both groups of subjects. The analysis by Western blot also showed that the ratio between isoforms (D2/FL) decreased after stimulation in HC, while it increased in CD subjects (Fig. 5f,g ). Relative expression of Tbet was used as positive control to confirm the efficacy of IFN-g stimulation (Supporting information, Fig. S1 ) To confirm that the modulatory effect on FoxP3 isoforms in HC subjects was due to the combination of the proinflammatory cytokine and the microbialderived metabolite, we stimulated PBMC from HC and CD subjects with each molecule separately. Our paired analysis showed that neither IFN-g nor butyrate alone had any effect in altering the ratio between FoxP3 isoforms in HC or CD subjects (Fig. 6a,b) .
Microbial-derived lactate modulates FoxP3 isoforms expression in PBMC
We have shown previously that high levels of lactate and Lactobacilli spp. are detected in genetically predisposed infants just prior to the onset of CD [36] . We hypothesized that components characterizing the preclinical phase of the disease may prime the intestinal microenvironment of future CD patients and lead to the onset of the disease. To investigate this further, we stimulated PBMC from HC subjects and CD patients with lactate to evaluate if this metabolite may play a role in modulating FOXP3 isoforms expression. Although our analysis on HC and CD subjects did not show statistically significant changes in FOXP3 isoforms expression between the two culture conditions, upon stimulation with lactate both FOXP3 isoforms appeared to be expressed more significantly in CD patients compared to HC subjects (P < 0Á005) (Fig.   7a ). Additionally, in both groups of subjects FOXP3 D2 was expressed significantly more than its counterpart FL (P < 0Á005) (Fig. 7b) . The ratio between isoforms (D2/FL) did not appear to differ between the two groups of subjects or between culture conditions (Fig. 7c) . The protein levels of FoxP3 were measured in PBMC by flow cytometry rather than by Western blot. By looking at the genic expression we observed that both isoforms were increased in CD compared to HC after stimulation with lactate, therefore we did not find it necessary to look at the protein levels of each isoform separately. We found it to be more appropriate to measure the total FoxP3 expression. Furthermore, flow cytometry allowed us to confirm that the increased expression of FoxP3 in CD was due to T reg cell population and not to other FoxP3-expressing cells. Our flow cytometry analysis confirmed the increased expression of total FoxP3 protein in CD patients compared to HC subjects after stimulation with lactate (P < 0Á05) ( Fig. 7d and Supporting information, Fig. S2 ).
Effect of butyrate and IFN-g on the expression of FoxP3 isoforms in CD4
1 CD25 1 T reg and CD4
1
CD25 -T cells
It has been shown that, upon activation, FoxP3 expression is up-regulated in CD4 1 CD25 -T cells [37] . This confers a transient suppressive function to this subset of cells. To . PBMC from healthy controls (HC) and CD patients in remission were cultured for 24 h with medium alone or with 1 mg/ml of PTG. Relative expression of FOXP3 isoforms normalized to housekeeping gene 18S expression was measured before and after stimulation in HC (n 5 7) and CD (n 5 7) patients (a). Paired analysis was used to determine the differences between the two isoforms' expression within the same group of patients in both culture conditions (b). Each dot represents the mean among the mRNA expression values 6 standard error of the mean (s.e.m.). The ratio between the relative expressions of FOXP3 isoforms (D2/FL) was calculated individually for each subject in HC and CD cultured with medium alone or stimulated with PTG. The bars show the mean of the ratios 6 s.e.m. in PBMC of HC and CD patients without stimulus (black bars) or stimulated with PTG (white bars) (c). Relative expression of interleukin (IL)6 was measured as a positive control of the efficacy of the PBMC stimulation with PTG in PBMC from HC (n 5 6) and CD (n 5 6) (D). Statistical comparisons were made using Wilcoxon's test (a,b,d), the Mann-Whitney U-test (b,d) and the Kruskal-Wallis test (c). *P < 0Á05.
Regulation of FoxP3 isoforms in coeliac disease
V C 2017 British Society for Immunology, Clinical and Experimental Immunology, 187: 490-506 PBMC from healthy controls (HC) (n 5 8) and coeliac disease (CD) patients in remission (n 5 10) were cultured for 48 hours in medium alone (MED) or stimulated with 100 ng/ml of IFN-g and 1 lg/ml of butyrate (STIM). Relative expression of FOXP3 and RORcT was measured by relative real-time reverse transcription-polymerase chain reaction (RT-PCR) using specific primers for the two isoforms and normalized to housekeeping gene 18S (a,d). The ratio between the relative expressions of FOXP3 isoforms (D2/FL) was calculated individually for each subject in HC and CD cultured with medium alone (MED) or stimulated (STIM). The bars show the mean of the ratios 6 standard error of the mean (s.e.m.) in PBMC of HC and CD patients without stimuli (black bars) or stimulated with butyrate and IFN-g (white bars) (b). Paired analysis was used to determine further the differences between the two isoforms' expression within the same group of patients (c). Each dot represents the mean among the mRNA expression values 6 s.e.m. Negative correlation between the expression of RORcT and the ratio FOXP3 FL/D2 was confirmed by two-tailed Spearman's correlation analysis (e). Protein levels of splice variants were analysed by Western blot using isoform-non-specific a-FoxP3 antibody PCH101. The ratio between FoxP3 isoforms (D2/FL) was calculated normalizing the relative protein expression of each isoform to b-actin in PBMC isolated from HC (n 5 3) and CD subjects (n 5 3) before (MED) and after stimulation (STIM) (f). Western blot analysis of FoxP3 protein detection in PBMC cultured with medium alone (MED) or with butyrate and IFN-g (STIM) is representative of three independent experiments on PBMC from HC and CD patients (g). Statistical comparisons were made using Wilcoxon's test or paired t-test. *P < 0Á05; **P < 0Á005.
isolated from CD patients (Fig. 8a) . However, the ratios between isoforms (D2/FL) did not differ between HC and CD subjects (Fig. 8b) . Conversely to what we saw in the T reg cell population, our experiments on CD4 1 CD25 -T cells showed that stimulation with IFN-g and butyrate did not have a modulatory effect on the FOXP3 isoforms, with FOXP3 D2 being expressed more sustainably than its counterpart FL (Fig. 8c) , and that the ratio between isoforms (D2/FL) did not change between the two groups of patients (Fig. 8d) .
Effect of lactate on FoxP3 isoforms expression on CD4 T reg from HC and CD patients and cultured them with or without lactate. Our data showed that stimulation of T reg cells with lactate did not trigger any increase in FOXP3 isoforms expression in CD patients compared to HC subjects, nor were there differences between the two cultures conditions (Fig. 9a) , therefore refuting the hypothesis that this microbial-derived metabolite targets T reg cells directly. Interestingly, the stimulation of CD4 1 CD25 -T cells led to a higher expression of FOXP3 FL (P < 0Á05) in CD patients compared to HC subjects, but not of FOXP3 D2 (Fig. 9b) .
Discussion
FoxP3 is a transcription factor fundamental for the suppressive function and differentiation of T reg cells. In this study we report a higher expression of the alternatively spliced isoform FOXP3 D2 in the intestine of CDA patients compared to non-coeliac controls, while no differences were seen in the expression of FOXP3 FL. Conversely to what was previously reported in the literature [33] , our data on CDGF showed a higher expression of both FOXP3 isoforms in this group of patients. Interestingly, however, we found that in CDA patients the relative amount of FOXP3 D2 in the gut mucosa was higher than the FL, while HC subjects and CDGF patients presented a similar expression of both isoforms. These findings underscore the importance that the altered intestinal ratio between FoxP3 isoforms may have on the pathogenesis of CD. The spliced isoform FoxP3 D2 has been described as less efficient in down-regulating RORgT/aT expression compared to its counterpart FL [17] . Our data demonstrated that the overexpression of FOXP3 D2 matched with higher mRNA levels Paired analysis was used to determine the differences between the two isoforms' expression within the same group of patients in PBMC from healthy controls (HC) (n 5 12 for the IFN-g experiment and n 5 19 for the butyrate experiment) and CD (n 5 10 for the IFN-g experiment and n 5 20 for the butyrate experiment) subjects were cultured for 48 h in medium alone or stimulated with either 100 ng/ml of IFN-g (a) or 1 lg/ml of butyrate (b). Each dot represents the mean among the mRNA expression values 6 standard error of the mean (s.e.m.). Differences between the relative expression of FOXP3 isoforms within each group was determined in HC and CD in both culture conditions. Relative real-time reverse transcription-polymerase chain reaction (RT-PCR) data were normalized to housekeeping gene 18S. Statistical comparisons were made using Wilcoxon's test or paired t-test (a,b). *P < 0Á05; **P < 0Á005. of RORcT. Furthermore, we also found a positive correlation between the expression of FOXP3D2, RORcT and IL17A. Taken together, these findings confirmed the deficiency of the D2 isoform in down-regulating the Th17 master transcription factor. Previous studies have reported an increase in the number of T reg cells in CD patients and suggested that functional impairments in their suppressive function may be related to the onset of the disease [29] [30] [31] [32] . The exact mechanisms that cause the altered regulatory activity of T reg cells in CD, however, are not understood fully. As the active state of the disease has been associated with a proinflammatory Th17-driven response [25, 26] , we The effect of lactate (1 lg/ml) on FOXP3 isoforms expression was evaluated by real-time reverse transcription-polymerase chain reaction (RT-PCR) on PBMC from non-coeliac subjects (HC n 5 16) and coeliac patients (CD n 5 23) after a 48-h stimulation and normalized on 18S (a). Paired analysis was used to determine differences between the two isoforms' expression within each group of patients in both cultures conditions (b). Each dot represents the mean among the mRNA expression values 6 standard error of the mean (s.e.m.). The ratio between the relative expressions of FOXP3 isoforms (D2/FL) was calculated individually for each subject in HC and CD cultured with medium alone or stimulated. The bars show the mean of the ratios 6 s.e.m. in PBMC of HC and CD patients without stimuli (black bars) or stimulated with lactate (white bars) (c). Flow cytometry was used to determine the protein levels of total FoxP3 before and after stimulation in HC (n 5 5) and CD (n 5 5) subjects. The percentage of CD4 ,d) and the Mann-Whitney U-test (b,c). *P < 0Á05; **P < 0Á005. infer from our data that the imbalance between FOXP3 isoforms may play a role in triggering and activating this Th17 response in a subgroup of CD patients. Our data from PBMC isolated from whole blood suggest a contribution of the intestinal microenvironment in modulating the ratio between FoxP3 isoforms. The intestinal lamina propria is considered one of the largest interfaces between the host and its external surroundings. T cells are particularly susceptible to different stimuli such as cytokines that have been shown to play a fundamental role in shaping the outcome of the immune response [38] . Additionally, the microbiome has been described to interact directly with immune cells to either promote or down-regulate inflammatory processes [39] , and several studies have reported an association between CD and intestinal dysbiosis [40] [41] [42] .
Regulation of FoxP3 isoforms in coeliac disease
We have shown that the combination of proinflammatory cytokine IFN-g plus microbial-derived butyrate creates a gut micromilieu that, by epigenetic pressure, establishes equilibrium between the two isoforms in HC subjects, while the same balance is not reached in PBMC from CD patients. Interestingly, the same effect was not seen when the PBMC were stimulated with only one of the two molecules, therefore underscoring a synergistic action of IFN-g with the microbial-derived metabolite. Our studies on different subsets of T cells (namely CD4 1 CD25 -T effector cells and CD4 1 CD25 11 T reg cells) confirmed that the short chain fatty acid and the proinflammatory cytokine target T reg cells directly. In line with our findings that a specific gut microenvironment during gut homing may influence the alternative splicing machinery, Mailer et al. showed that patients affected by Crohn's disease display an increased expression of the less common FoxP3 isoform lacking exon 7 and that proinflammatory cytokine IL-1b induced the alternative splicing [43] . The importance of butyrate in the regulation of the immune system is well described. This short chain fatty acid has been shown to induce FoxP3 expression and T reg cell differentiation in the colonic lamina propria and to promote FOXP3 promoter respectively, by double-positive and -negative selection and cultured for 48 h with medium alone or with 1 lg/ml of lactate. The relative expression of FOXP3 isoforms was normalized on 18S. Statistical comparisons were made using Wilcoxon's test (a) and the Mann-Whitney Utest (b). *P < 0Á05; **P < 0Á005.
acetylation [44] [45] [46] . Based on our data, we hypothesize that the balance between FOXP3 isoforms in HC subjects after stimulation with IFN-g and butyrate may represent a compensatory mechanism of T reg cells in becoming more efficient at responding to mucosal inflammation. The sustained imbalance between the two isoforms that we reported in CD patients may account, instead, for the lack of proper anti-inflammatory response and the subsequent chronic mucosal inflammatory process that characterizes the active state of the disease despite the high number of T reg cells. These findings emphasize the hypothesis that innate defects in T reg cell population can lead to a different response to the same microenvironment and eventually trigger an inefficient immune regulation. Additional studies are warranted to understand more clearly the mechanisms by which IFN-g and butyrate synergize to restore equilibrium between FOXP3 isoforms in HC subjects and how, conversely, this does not occur in CD patients. The ) cells (4) . CD patients, however, seem to be more responsive to lactate and show an increase in the total pool of FoxP3 1 cells compared to HC as a possible compensatory mechanism to maintain a high level of functional FoxP3 1 FL isoform (5) . During the active state of the disease the small intestine of CD patients is characterized by a drop in lactate levels, an increased intestinal permeability due to the interaction between gliadin and epithelial cells (6) and high production of butyrate from the microbial flora (7). Furthermore, expanded intraepithelial lymphocytes (IELs) produce a high amount of proinflammatory cytokines such as interferon (IFN)-g and interleukin (IL)-17 (8) . The increased intestinal permeability allows gliadin peptides to translocate to the lamina propria of the small intestine, where they are recognized by APC (9) . This triggers an adaptive immune response that is T helper type 1 (Th1)/Th17-driven and characterized by high production of proinflammatory IL-17 and IFN-g. In HC subjects the local micro-milieu characterized by this proinflammatory environment and microbiome-derived excess butyrate causes the FoxP3 epigenetic switch toward the more functional (and, therefore, more protective) FL isoform restoring the equilibrium between FoxP3 isoforms (10 [47, 48] . The intestinal immune system is known to play an important role in establishing the tolerogenic environment to commensal bacteria [49] , and the microbiome itself is fundamental in shaping the immune system [50, 51] . We have previously reported the proof of concept that infants genetically predisposed to CD are characterized by increased production of lactate associated with enrichment in Lactobacilli spp. in the preclinical phase, followed by a sharp drop of both just before the onset of the disease. The same metabolomic profile was not detected in children who did not develop CD [36] . In the present study we have shown that, upon stimulation with lactate, PBMC from CD patients expressed higher levels of both FOXP3 isoforms compared to non-coeliac HC subjects, therefore confirming once again how cells from CD patients respond differently to the same microenvironment. As Lactobacilli spp. have been shown to enhance the integrity of the intestinal barrier and to shape the immune system in a protective manner [52, 53] , it is conceivable to hypothesize that the increased FOXP3 expression in response to lactate may represent a preclinical compensatory mechanism in CD at-risk patients to down-regulate the inflammation. The following drop then may contribute to the definitive loss of gluten tolerance and the subsequent onset of disease. This theory is supported by the evidence that longitudinal studies of infants at-risk for CD have shown that, in the preclinical phase, the onset of the autoimmune process as shown by the appearance of anti-tissue transglutaminase autoantibodies is dynamic and reversible, with 50-80% of subjects showing normalization of the autoantibody titres without any dietary intervention [54, 55] . Our experiments on T effector and T reg cells, however, suggest that this microbial-derived metabolite does not modulate FOXP3 expression directly, but probably exerts its effect through other cells such as APC. In line with our findings, Goodman et al. reported that the probiotic Lactobacillus family contains suppressive motifs that interact with APC signals [39] . Furthermore, L. crispatus has been shown to be able to induce human dendritic cell proliferation and to confer to them an anti-inflammatory phenotype [56] . Further studies are needed to understand more clearly the role of lactate in the preclinical phase of the disease and how this may affect the suppressive function of T reg cells. Collectively from these findings, we hypothesize the following sequence of events ( Fig. 10 ): while circulating in the blood, T reg cells are characterized by an over-expression of less functional FoxP3 D2 over functional FL. Once recruited to the intestinal compartment, the specific microenvironment of HC or CD subjects modulates differentially the expression of both isoforms. The high production of lactate that characterizes the preclinical state of CD triggers an increased expression of FoxP3 in CD patients compared to HC, while the ratio between the isoforms is maintained imbalanced. This microbial-derived metabolite, however, does not target T reg cells directly, but probably acts on APC. During the active state of the disease, the intestine is characterized by increased intestinal permeability and a proinflammatory IFN-g enriched microenvironment related to microbiota dysbiosis (as mimicked by excessive butyrate production). These conditions trigger an efficient regulatory immune response in HC subjects by modulating directly the balance between FoxP3 isoforms, while intrinsic defects on T reg cells do not allow this balance to occur in CD patients. In summary, our study demonstrates for the first time a direct and mechanistic link between microbiota-derived metabolites, mucosal inflammatory processes and epigenetic changes regulating FOXP3 isoform expression and how these mechanisms lead towards a Th17-driven immune response in CD subjects. Our data highlight the multi-factorial nature of CD and provide a set of new possible targets for the prevention of CD in genetically susceptible individuals.
Supporting information
Additional Supporting Information may be found in the online version of this article at the publisher's web-site. Fig. S1 . Relative expression of TBET in peripheral blood mononuclear cells (PBMC) upon stimulation with butyrate and interferon (IFN)-g. Relative expression of TBET was measured as a positive control of the efficacy of PBMC stimulation with IFN-g and butyrate. PBMC (n 5 11) were cultured for 48 h in complete medium alone (MED) or stimulated with 100 ng/ml of IFN-g and 1 lg/ml of butyrate (STIM). Relative expression of TBET was normalized on housekeeping gene 18S. Statistical comparisons were made using Wilcoxon's test. **P < 0Á005. 
